|
|
|
|
|
|
|
|
|
|
|
da Vinci ® Robotic Assisted Laparoscopic Prostatectomy
Clinically evident prostate cancer affects one in six men and is the second most common cause of cancer death. Because the incidence of prostate cancer increases with age and the life expectancy of American men is increasing, the number of men with prostate cancer is expected to rise. The surgeons of Tri-County Urologists offer all modalities of treatment for prostate cancer, including the da Vinci ® Robotic Assisted Laparoscopic Prostatectomy. The implementation of this new and exciting surgical technology at Tri-County Urologists is being led by Jon Suleskey, D.O. and Darryl Reaume, D.O.
Why surgery as a treatment for prostate cancer? Surgery provides the highest durable chance for cure. Quality of life studies show patients are happier and healthier at one year and three years post treatment over all other modalities. The goal of surgery is many fold:
- To cure the patient of cancer (80% at 5 years, 77% at 15 years)
- To preserve continence (92% dry at 1 year)
- To preserve sexual function (76% potent – age less than 60 years)
The da Vinci ® robotic minimally invasive prostatectomy provides a number of benefits to the patient a number of benefits:
- Safer surgery with less blood loss (typically less than 500 cc)
- Less scarring Shorter length of hospital stay (usually one day)
- Reduced pain and pain medications Faster recovery and return to work
Tri-County Urologists surgeons have performed successfully hundreds of radical prostatectomies utilizing may methods. The proven minimally invasive da Vinci ® robotic assisted technology now used by our experienced surgeons is making a significant difference in the health of our community.
Further information provided below is excerpted by permission from an article that appeared in a recent issue of Focus, a Mount Clemens General Hospital publication. You may also learn more about Mount Clemens General Hospital by clicking on the following link: www.mcgh.org
|
|
|
|
|
|
|
|